☆ 4.7 Letter

Effect of Treatment for 12 Weeks With Rilapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, on Arterial Inflammation as Assessed With 18F-Fluorodeoxyglucose-Positron Emission Tomography Imaging

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Get Full Text
Add to Collection

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 63, Issue 1, Pages 86-88

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2013.07.050

Keywords

-

Categories

Cardiac & Cardiovascular Systems

Funding

  1. Academy of Medical Sciences (AMS) [AMS-SGCL1-Rudd] Funding Source: researchfish
  2. British Heart Foundation [PG/09/083/27667, FS/12/29/29463] Funding Source: researchfish
  3. British Heart Foundation [PG/09/083/27667, FS/12/29/29463] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.